Cholesterol
Third Report of the
National Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment
Panel III)
Executive Summary (pdf, 40 pages)
This document contains treatment recommendations derived from the evidence-based full ATP III report. Key tables and figures from the full report are included for easy reference. Topics addressed in the executive summary include classification of lipids and lipoproteins, coronary heart disease (CHD) risk assessment, lifestyle interventions, drug treatment, and interventions to improve adherence. Recommendations for special populations such as patients with CHD, patients at high risk for developing CHD, patients with diabetes, women, older Americans, young adults, and racial and ethnic groups are provided. NIH Publication No. 01-3670.
Full Report (pdf, 284 pages)
The ATP III full set of guidelines is an evidence-based, extensively referenced report that is the basis for several related products and tools. The ATP III guidelines provide detailed information on topic areas such as classification of lipids and lipoproteins, coronary heart disease (CHD) risk assessment, lifestyle interventions, drug treatment, specific dyslipidemias, and adherence issues. Recommendations for special populations such as patients with CHD, patients at high risk for developing CHD, patients with diabetes, women, older Americans, young adults, and racial and ethnic groups are provided. NIH Publication No. 02-5215.
Implications of Recent Clinical Trials (pdf, 13 pages)
Since the publication of ATP III, 5 major clinical trials of statin therapy with clinical end points have been published. These trials addressed issues that were not examined in previous clinical trials of cholesterol-lowering therapy. This document reviews the results of these recent trials and assesses their implications for cholesterol management.
Cholesterol Screening Guidelines (pdf, 16 pages)
This 1995 update of the 1989 screening guidelines provides recommendations for cholesterol screening outside of the traditional medical setting. Two new features of the guidelines include the measurement of HDL lipoprotein cholesterol as part of initial cholesterol testing and more aggressive measurement and treatment to lower cholesterol in patients with coronary heart disease. NIH Publication No. 95-3045.
Cholesterol
Management for
your Palm OS PDA (no Pocket
PC available)
This interactive guideline tool will assist the clinician in implementing the ATP III Cholesterol Guidelines at the point of care.
The program also contains usable information from ATP III including:
- ATP III classification of lipid levels.
- ATP III CHD risk assessment.
- Therapeutic Lifestyle Changes (TLC).
- Drug therapy for lipid lowering.
- Information on the metabolic syndrome.
- Issues for special populations.
Activity Study | Drug Information | Treatment Guidelines | Immunization Delivery | Best Practices | Patient Safety | Oregon Law Shortcuts | State Health Plans | Third Party Insurance Info | MEDICARE Shortcuts | FDA Shortcuts | CDC Shortcuts | References & Journals | Associations | Services & Insurance
